Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Errata-corrige. Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis.
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Established and novel disease-modifying treatments in multiple sclerosis.
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - NO.
Cognitive-motor related brain activity during walking: differences between men and women with multiple sclerosis.
Perspectives on cytokine-directed therapies in multiple sclerosis.
Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure.
A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis.
Cognitive function alone is a poor predictor of health-related quality of life in employed patients with MS: results from a cross-sectional study.
Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI.
[LINGO-1 Expression of brain tissue in Experimental Autoimmune Encephalomyelitis Mouse].
Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models.
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.
Is there a cognitive signature for MS-related fatigue?
Bioconcentration, metabolism and neurotoxicity of the organophorous flame retardant 1,3-dichloro 2-propyl phosphate (TDCPP) to zebrafish.
Can meditation influence quality of life, depression, and disease outcome in multiple sclerosis? Findings from a large international web-based study.
GM-CSF promotes migration of human monocytes across the blood brain barrier.
Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis.
Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1.
Artificial reproductive techniques in multiple sclerosis.
Overexpression of SIRT1 Protein in Neurons Protects against Experimental Autoimmune Encephalomyelitis through Activation of Multiple SIRT1 Targets.
Premature immune senescence in children with MS: Too young to go steady.
PGE2 contributes to in vitro MSC-mediated inhibition of non-specific- and antigen-specific T cells proliferation in MS patients.
Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.
The stress-buffering effects of hope on changes in adjustment to caregiving in multiple sclerosis.
Pages
« first
‹ previous
…
535
536
537
538
539
540
541
542
543
…
next ›
last »